Cancer Nursing Practice

Search query:

Filter by section

Filter by keyword

Filter by author

Filter by date

Results 1 - 4 of 4 Search Tips

Nurses’ safety during cancer therapy must be a priority

07 January 2019

Cancer Nursing Practice

Opinion

Nurses administering systemic anticancer therapy (SACT) agents are at risk of consistent exposure to hazardous drugs known to cause health hazards. Long and...

Systemic anticancer therapy handling safety: healthcare workers’ awareness, knowledge, training and use of protection measures

10 October 2019

Cancer Nursing Practice

Safety

Healthcare workers who handle or administer systemic anticancer therapy (SACT) agents are at risk of exposure to hazardous drugs known to be carcinogenic, mutagenic...

Protecting nurses against the risks of occupational exposure to systemic anticancer therapy agents

30 December 2020

Cancer Nursing Practice

nurse well-being

Many agents used for systemic anticancer therapy (SACT), which include chemotherapy drugs, monoclonal antibodies and other biological therapies, are known to be...

Chimeric antigen receptor (CAR) T-cell therapy: an overview for nurses

09 September 2024

Nursing Standard

Peer-reviewed articles

Chimeric antigen receptor (CAR) T-cell therapy is a relatively new and innovative immunotherapy for haemato-oncological diseases. In the UK, CAR T-cell therapy can...

04 November 2024 / Vol 23 issue 6

TABLE OF CONTENTS

DIGITAL EDITION

SUBSCRIBE

5 Most Read Articles
Journals
Other RCNi websites